|
HS Code |
226299 |
| Cas Number | 446-41-1 |
| Molecular Formula | C6H5BrFN |
| Molecular Weight | 190.01 g/mol |
| Appearance | Light yellow to brown solid |
| Melting Point | 43-47°C |
| Boiling Point | 258°C |
| Density | 1.72 g/cm³ |
| Purity | Typically ≥98% |
| Solubility | Slightly soluble in water, soluble in organic solvents |
| Synonyms | 2-Fluoro-4-bromoaniline |
| Smiles | c1cc(Br)ccc1N |
| Inchi | InChI=1S/C6H5BrFN/c7-5-2-1-4(9)3-6(5)8/h1-3H,9H2 |
As an accredited 4-Bromo-2-Fluoroaniline factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Amber glass bottle containing 25 grams of 4-Bromo-2-Fluoroaniline, securely sealed with a screw cap and labeled with hazard information. |
| Shipping | 4-Bromo-2-Fluoroaniline is shipped in sealed, chemically-resistant containers, compliant with international transport regulations for hazardous chemicals. Packaging ensures protection from moisture, sunlight, and physical damage. Proper labeling and documentation, including safety data sheets, accompany shipments to safeguard handlers and meet regulatory requirements for safe transport of potentially harmful substances. |
| Storage | 4-Bromo-2-Fluoroaniline should be stored in a cool, dry, well-ventilated area, away from direct sunlight and incompatible substances such as strong oxidizing agents. Keep the container tightly closed and clearly labeled. Avoid moisture and store at room temperature or as recommended by the manufacturer. Use appropriate safety measures to prevent inhalation, ingestion, or skin contact. |
Applications of 4-Bromo-2-Fluoroaniline in Industrial ManufacturingAs a specialized manufacturer of 4-Bromo-2-Fluoroaniline, we supply high-purity material consistently integrated by formulators and processors in advanced industrial sectors. Our downstream customers benefit from this building block within multiple high-value synthesis pathways. Below, we highlight the key application scenarios, compliance requirements, process routes, and the final output types realized through its use. 1. Pharmaceutical Intermediate for Active Pharmaceutical Ingredient SynthesisPharmaceutical manufacturers employ 4-Bromo-2-Fluoroaniline as a crucial intermediate for constructing a range of complex APIs, particularly within small molecule heterocyclic frameworks such as kinase inhibitors and CNS drugs. Used in the early amidation or palladium-catalyzed coupling stage, the intermediate offers selectivity and reactivity that streamline the synthetic steps required for drug substance development and commercialization. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Agrochemical Active Compound SynthesisProducers of crop protection chemicals use 4-Bromo-2-Fluoroaniline as a targeted amine source in the manufacture of fluorinated herbicide and fungicide active ingredients. The compound’s dual halogenation enables precise substitution patterns essential for new-generation pesticidal efficacy, stability, and regulatory-accepted degradation profiles required by global authorization frameworks. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Dye and Pigment Manufacturing for Specialty ColorsManufacturers of high-value dyes and pigments incorporate 4-Bromo-2-Fluoroaniline as a functionalized aromatic amine precursor in the synthesis of advanced azo and heterocyclic colorants. Its unique substitution supports fastness and stability profiles for technical textile, plastic, and coating sectors operating under stringent international color safety and consistency standards. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Advanced Material and Polymer Modifier SynthesisSpecialty polymers and engineered materials, especially for electronics and high performance applications, utilize 4-Bromo-2-Fluoroaniline within custom monomer and crosslinker formation. Formulators employ its structural features to confer reactivity and functional group anchoring for advanced materials, while ensuring conformance to electrical and fire safety protocols critical in today’s electronics and automotive platforms. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive 4-Bromo-2-Fluoroaniline prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
As a chemical producer with years behind the reactors, precision and repeatability have become points of pride. 4-Bromo-2-fluoroaniline sits among our core specialty aromatic halides. Chemists working in the pharmaceutical and agrochemical space often chase purity, exacting substitution patterns, and lot-to-lot repeatability. Our processes use only high-grade raw materials—never recycling spent intermediates—to keep impurities at a minimum throughout every kilogram we produce. We constantly analyze not just the main component but also the trace side-products that tend to trip up scale-up and regulatory testing.
The standard product type goes by the chemical name 4-Bromo-2-fluoroaniline, with the typical model labeled simply as 'AR' for analytical grade manufacturing. Our last batch produced in June 2024 achieved a GC purity above 99.5%. Defining a product by its composition alone tells only half the story. Synthesis routes using direct halogenation often leave residual isomers that alter downstream reactivity. We use a stepwise halogen exchange protocol, optimizing temperature ramp and solvent balance for minimal cross-contamination, leading to tight control over not just Br and F incorporation but also trace residuals like polyhalogenated anilines, which pharmaceutical process engineers rightly scrutinize.
In the drum room, before any order leaves the plant, our techs look beyond analytical purity. Particle size uniformity, resistance to caking, and hygroscopicity are all logged and recalibrated with process tweaks demanded by end users. For 4-bromo-2-fluoroaniline, most production targets a free-flowing, faintly beige crystalline solid. Only minor, expected lot-to-lot color differences stem from the purification yields at scale, never from carryover of colored precursors or uncontrolled byproduct formation. We vacuum-pack the material and use inert nitrogen overlay to cut oxygen exposure, and our operators report every lot’s visual appearance against control standards—this is not only customer assurance, but an internal check to spot any deviation in process subtle enough to escape HPLC but obvious to the eye.
Based on melting point assessments made freshly on-site (typically around 73-76°C, with less than 1°C batch deviation), we can pinpoint any incremental drift that would indicate solvent residue or unseen impurities. Moisture levels hang consistently below 0.10%, monitored by Karl Fischer titration with each lot. Not every chemist will need that specification, but once you’ve faced stuck filters or batch caking during recovery, those details matter. Packing lines regularly wipe down all contact equipment between product switchovers—cross-contamination checks are a standing part of QA audits, not just filler for documentation.
Our formulation chemists know that building blocks like 4-bromo-2-fluoroaniline lay the backbone for innovation. Its primary use lands in synthesis of active pharmaceutical ingredients, especially for targeted kinase inhibitors and complex fluorinated heterocycles. With the electron-withdrawing fluoro and bromo groups para- and ortho- to the amino position, the product offers a unique reactivity profile—not an interchangeable cog. For Suzuki, Buchwald, or Ullmann cross-couplings, reactivity differs markedly from simple fluoroanilines or bromoanilines. The increased electron density from the amino group shifts the substrate into higher nucleophilicity, while bromo offers a balance between good leaving group ability and selectivity. It’s the difference between a clean coupling and a stubborn, low-yielding intermediate.
Customers who have shifted from multi-halogenated aniline stocks to this product often report improved process consistency. Synthetic organic chemists have written in to share that, with our controlled crystallinity, they see fewer issues scaling up reactions, especially in automated reactors aiming for hundreds of kilograms. Side reactions, particularly during heterocyclic ring formation, often fall away when feedstock quality remains stable.
Comparisons with plain 2-fluoroaniline or 4-bromoaniline highlight the nuanced value of this dual substitution pattern. The para-bromo influences subsequent functionalization strategies, such as palladium-catalyzed cross-couplings, by tuning both electron distribution and steric interactions. Using 4-bromo-2-fluoroaniline rather than the monosubstituted versions allows access to unique substitution patterns within aromatic rings. Intermediates generated from this feedstock often serve as scaffolds in agrochemical and medicinal chemistry pipelines, where even minor changes in substitution order lead to substantial shifts in bioactivity.
Several project partners in pharma have found that the higher blocking effect of the bromo group limits unwanted ortho substitution, steering reactions cleanly toward desired products. During custom syntheses, feedback from process chemists points to easier monitoring by NMR and MS: the presence of two heavy atoms at defined positions simplifies spectral analysis. By maintaining strict control over halogen placement, we remove a common stumbling block—product batch failure due to regioisomeric byproducts. Lesser quality feedstocks, or those from resellers blending different manufacturing streams, routinely show confusing sidebands and broadened NMR traces, a headache our customers remind us they can live without.
Our production engineers revisit every step after customer feedback. Difficulty filtering? We’ll screen tighter for particles above 300 microns. Unexpected reactivity? We review trace metal and halide content, and modify purification solvents if persistent. All handling—grinding, packing, transport—takes place in humidity-controlled zones. Shipment delays cause temperature spikes across regions, so we repeat stability checks under both cool and elevated conditions, logging visual and analytical changes with photos and chromatograms stored for every lot.
Older batch records show that early runs, before adoption of integrated online NMR, drifted by as much as 1.5% in byproduct content. Retooling our purification refined those numbers, and partner labs came back with higher yields in pilot-scale pharma applications. We don’t see complaints about batch-to-batch variance since switching the synthetic protocol two years ago. Now, requests for COAs specifying not just purity, but residual halide, trace metals, and particle size ranges, see rapid turnaround because we already prep these figures as a matter of routine, knowing what researchers want before they ask.
For scale-up teams planning to introduce 4-bromo-2-fluoroaniline into a synthetic route, solubility and compatibility questions often come up. This aromatic intermediate dissolves freely in chlorinated solvents—DCM, chloroform, and DMF all work—and holds consistent performance in charged nucleophilic substitution. Our technical advice desk, staffed by chemists who ran these same reactions before graduating to plant roles, fields questions daily on minor tweaks in method: “Would a switch to toluene help?” “Is batch warming above 60°C risking decomposition?” We draw from hundreds of production runs, sharing real numbers on yield loss, recovery times, and clean-up solvent quantities so customers can skip the trial-and-error phase.
Pharmaceutical projects depend on reliability, not just stats. Field failures—where a final intermediate falls short of regulatory compliance—cause more lost hours than anyone likes to admit. Feedstocks that vary in impurity or handle unpredictably risk cascading failures through months of process validation. By supplying this product with assured, documented quality and rapid, on-request technical support, we cut down on uncertainty and lower the real cost of introducing a new raw material.
As the market shifts, especially with increased demand for fluorinated and brominated aromatics driven by the development of new kinase inhibitors and crop protection agents, users bring us new challenges. We pay attention when customers report filtration difficulties, unusual melting points, or reaction side-products, tracking each as a chance to recalibrate. On occasion, a run of product did not decolorize as expected; a deeper dive traced this to a single batch of precursor, swapped out as a result. Each point of feedback translates to a running improvement log. We log more than just numbers: every insight from an overseas partner or a local formulation chemist becomes a practical adjustment in our SOPs.
We don’t rely solely on customer insight. Internal workshops are held at regular intervals where our production and R&D teams run side-by-side batches of 4-bromo-2-fluoroaniline using variant reaction conditions, then stress test for handling and reactivity. Those findings drive subtle shifts that get written into offerings for commercial-scale buyers. Plant-scale chemists—who once spent long shifts monitoring pressure and color—regularly collaborate directly with bench scientists using our materials, creating a tight feedback loop that minimizes unpleasant surprises.
Some project collaborators, especially from custom synthesis outfits, run into unique requirements: exceptionally fine or coarse particle sizes for specialized reactor feeds, or solvent-specific solubilized forms. We obligate ourselves to provide not just a single high-spec product, but a modest range that avoids overcomplicating production while providing real options for partners. Custom orders often lead to process upgrades that improve the baseline material, benefitting all customers in the long term. New challenges—such as requirements for ultra-low residual solvents to meet evolving environmental guidelines—get rolled rapidly into our QA process thanks to both modern instrumentation and an entrenched operator culture of double-checking.
This product, as shipped, comes backed with certificate documentation that has evolved beyond simple HPLC snapshots. Customers who move into regulated markets demand expanded trace metal, halide, and impurity profiles. Our approach is to anticipate and update, never waiting for a regulatory push before bringing the documentation online.
Each facility producing 4-bromo-2-fluoroaniline adheres to environmental regulations—not only at the point of finished product, but also throughout the byproduct and waste handling streams. We’ve replaced legacy solvents with less impactful alternatives, wherever this keeps process reliability intact. Effluent tracking, a frequent topic in partner audits, follows strict protocols long established. Any new impurity profile found in routine outputs prompts immediate process review and, where needed, full bench-to-plant revalidation.
Each production operator receives focused training on safe handling of anilines. Aromatic amines, as seasoned chemists know, carry specific hazards in inhalation and skin contact, necessitating containment throughout grinding and packing. Every new team member spends time on the floor working with experienced plant supervisors before stepping into an unsupervised role—cutting down on mistakes that could threaten both product and personnel.
Many specialty aromatic intermediates face recurring shortages when raw material supply falters or shipping lines choke. We learned this the hard way over the last half-decade, diversifying our sourcing and forging direct links with primary chemical producers in multiple regions. An unexpected benefit has been the opportunity to tweak starting materials toward higher purity, as improved logistics give longer lead times. By running annual audits of every upstream provider, we maintain a clearer picture of where risk lies, stepping in—or rerouting orders—well before a delay threatens manufacturing continuity.
All batches are date-coded, with records tracked electronically and hardcopy signed and archived, giving every customer the peace of mind that comes from provable traceability. We've heard stories from synthetic teams suddenly caught short by unreliable paper trails from non-manufacturer sources; it’s often only after a problem emerges that buyers wish they had factory-direct sourcing. In the worst-case scenario, plant downtime causes missed project milestones. Working direct with us—without layers of trading companies—means most customers avoid such roadblocks.
As scientific advances move, so do performance targets for building blocks like 4-bromo-2-fluoroaniline. Our R&D engineers maintain close partnerships with academic groups and industrial consortia, taking note of every new transition metal catalyst, emerging green chemistry route, and purification technology that comes to market. It's one thing to hold a product specification tight, but it's better still to integrate findings from outside research: competitor processes adopting cheaper catalysts or improved crystallization techniques do not stay unknown for long.
Partner calls often turn into shared learning sessions: What worked in your last scale-up? Which catalyst batch delivered the highest turnover? Our role as supplier stretches past the product container, making sure that every ounce of value, from application advice to proactive specification improvements, reaches those pushing their projects forward.
Product innovation, in our view, comes from the ground up. Researchers' requests shape not just pricing or logistics but the makeup of the compounds themselves. We’re seeing users demand not just higher grades, but multiple grades—analytical, ultra-pure for active API work, tailored crystalline forms for specialized reactors, solvent-wet variants for rapid in-solution use. Experience with 4-bromo-2-fluoroaniline has underscored how critical it remains to keep listening, as small detail shifts in physical or analytical characteristics can ripple through a supply chain.
Upcoming projects in specialty fluorinated and brominated aromatics point toward a rising need for supplier expertise and transparency, rather than simple commodity fulfillment. Production teams here remain committed to not just stamping out drums of material, but improving every link in the delivery chain, pulling on lessons from prior runs and current lab feedback.
Those who make their mark in pharma, agro, or materials science value relationships with manufacturers who care about both the molecule and its context. Every batch of 4-bromo-2-fluoroaniline that leaves our gate reflects decades of accumulated plant-floor and lab-bench experience. By continuing to share our processes, respond to real-world needs, and incorporate direct feedback from users at every stage, we build not just a stronger product, but a stronger chain of action, stretching from one chemist's hands to the next.